MaaT Pharma Announces First Patient Randomized in IMMUNOLIFE Phase 2 Study Sponsored by Gustave Roussy, in Advanced NSCLC ...
Gut microbiome researcher Purna C. Kashyap, MBBS, shares the latest insights on the role of probiotics, disorders of the ...
Probiotics will only be able to survive and flourish in the gut if you feed them with plenty of plants, so unfortunately just ...
IMMUNOLIFE, a Phase 2 randomized exploratory study, will evaluate the potential of MaaT033 in combination with Cemiplimab versus Best Investigator Choice (i.e.: second line) in enhancing disease ...
New Guidance Helps Parents Understand Infant Skin Vulnerability and Bacterial Imbalance A child's eczema severity often ...
Among healthy adults, inhaling wood smoke for 2 hours negatively impacted the lung microbiome by raising the amount of ...
According to MarketsandMarkets™, the Human Microbiome Drugs Market is projected to grow from about USD 0.35 billion in 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback